DIVA Laboratories Ltd (4153) — Capital Reinvestment Ratio
DIVA Laboratories Ltd (4153) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$5.57 Million) in capital expenditures (NT$241.00K). See how leveraged is DIVA Laboratories Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DIVA Laboratories Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks DIVA Laboratories Ltd's Capital Reinvestment Ratio across 7 annual periods. Check total reinvestment intensity of DIVA Laboratories Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for DIVA Laboratories Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for DIVA Laboratories Ltd from 2017 to 2025. For live market cap and broader valuation context, see how much is DIVA Laboratories Ltd worth.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | NT$20.77 Million | NT$1.00 Million | ▲ +178.2% |
| 2024 | 0.02x | NT$123.14 Million | NT$2.13 Million | ▼ -43.1% |
| 2023 | 0.03x | NT$252.91 Million | NT$7.69 Million | ▼ -80.5% |
| 2022 | 0.16x | NT$73.19 Million | NT$11.42 Million | ▼ -35.8% |
| 2019 | 0.24x | NT$52.66 Million | NT$12.79 Million | ▼ -3.8% |
| 2018 | 0.25x | NT$86.02 Million | NT$21.71 Million | ▼ -21.4% |
| 2017 | 0.32x | NT$41.45 Million | NT$13.31 Million | — |